814 related articles for article (PubMed ID: 19429984)
1. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
2. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit.
Ferracini R; Di Renzo MF; Scotlandi K; Baldini N; Olivero M; Lollini P; Cremona O; Campanacci M; Comoglio PM
Oncogene; 1995 Feb; 10(4):739-49. PubMed ID: 7862451
[TBL] [Abstract][Full Text] [Related]
3. Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma.
Kim CH; Moon SK; Bae JH; Lee JH; Han JH; Kim K; Choi EC
Acta Otolaryngol; 2006 Jan; 126(1):88-94. PubMed ID: 16308260
[TBL] [Abstract][Full Text] [Related]
4. Expression of hepatocyte growth factor and c-Met after spinal cord injury in rats.
Shimamura M; Sato N; Sata M; Wakayama K; Ogihara T; Morishita R
Brain Res; 2007 Jun; 1151():188-94. PubMed ID: 17425951
[TBL] [Abstract][Full Text] [Related]
5. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
Kim CH; Kim J; Kahng H; Choi EC
Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
[TBL] [Abstract][Full Text] [Related]
6. [Effect of hepatocyte growth factor on invasion of ovarian cancer cell line SKOV3 and its signal transduction pathway].
Wang HL; Zhang SL; Lu YM; Jiang JY; Zhu XY
Ai Zheng; 2006 May; 25(5):570-5. PubMed ID: 16687076
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor (HGF), HGF activator, and c-Met in synovial tissues in rheumatoid arthritis and osteoarthritis.
Nagashima M; Hasegawa J; Kato K; Yamazaki J; Nishigai K; Ishiwata T; Asano G; Yoshino S
J Rheumatol; 2001 Aug; 28(8):1772-8. PubMed ID: 11508578
[TBL] [Abstract][Full Text] [Related]
8. Sp1 regulates expression of MET, and ribozyme-induced down-regulation of MET in fibrosarcoma-derived human cells reduces or eliminates their tumorigenicity.
Liang H; O'Reilly S; Liu Y; Abounader R; Laterra J; Maher VM; McCormick JJ
Int J Oncol; 2004 May; 24(5):1057-67. PubMed ID: 15067326
[TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
Park HR; Min K; Kim HS; Jung WW; Park YK
Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
[TBL] [Abstract][Full Text] [Related]
10. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
[TBL] [Abstract][Full Text] [Related]
11. Post-ischemic delayed expression of hepatocyte growth factor and c-Met in mouse brain following focal cerebral ischemia.
Nagayama T; Nagayama M; Kohara S; Kamiguchi H; Shibuya M; Katoh Y; Itoh J; Shinohara Y
Brain Res; 2004 Mar; 999(2):155-66. PubMed ID: 14759494
[TBL] [Abstract][Full Text] [Related]
12. Expression and localization of hepatocyte growth factor and its receptor c-Met in inverted papillomas.
Choi JH; Lee SH; Lee HM; Lee SH; Jung HH; Choi J; Lim HW; Lee SW; Kang SM
Acta Otolaryngol; 2006 Jul; 126(7):724-9. PubMed ID: 16803712
[TBL] [Abstract][Full Text] [Related]
13. Expression of connexins in normal and neoplastic canine bone tissue.
Sanches DS; Pires CG; Fukumasu H; Cogliati B; Matsuzaki P; Chaible LM; Torres LN; Ferrigno CR; Dagli ML
Vet Pathol; 2009 Sep; 46(5):846-59. PubMed ID: 19429987
[TBL] [Abstract][Full Text] [Related]
14. c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma.
Tokunou M; Niki T; Eguchi K; Iba S; Tsuda H; Yamada T; Matsuno Y; Kondo H; Saitoh Y; Imamura H; Hirohashi S
Am J Pathol; 2001 Apr; 158(4):1451-63. PubMed ID: 11290563
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
[TBL] [Abstract][Full Text] [Related]
16. Bovine hepatocyte growth factor and its receptor c-Met: cDNA cloning and expression analysis in the mammary gland.
Yamaji D; Kimura K; Watanabe A; Kon Y; Iwanaga T; Soliman MM; Ahmed MM; Saito M
Domest Anim Endocrinol; 2006 Mar; 30(3):239-46. PubMed ID: 16207523
[TBL] [Abstract][Full Text] [Related]
17. Involvement of hepatocyte growth factor in branching morphogenesis of murine salivary gland.
Ikari T; Hiraki A; Seki K; Sugiura T; Matsumoto K; Shirasuna K
Dev Dyn; 2003 Oct; 228(2):173-84. PubMed ID: 14517989
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats.
Inoue H; Yokoyama F; Kita Y; Yoshiji H; Tsujimoto T; Deguchi A; Nakai S; Morishita A; Uchida N; Masaki T; Watanabe S; Kuriyama S
Int J Mol Med; 2006 May; 17(5):857-64. PubMed ID: 16596271
[TBL] [Abstract][Full Text] [Related]
19. Glucose transporter 1 expression in canine osteosarcoma.
Petty JC; Lana SE; Thamm DH; Charles JB; Bachand AM; Bush JM; Ehrhart EJ
Vet Comp Oncol; 2008 Jun; 6(2):133-40. PubMed ID: 19178673
[TBL] [Abstract][Full Text] [Related]
20. met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma.
De Maria R; Miretti S; Iussich S; Olivero M; Morello E; Bertotti A; Christensen JG; Biolatti B; Levine RA; Buracco P; Di Renzo MF
J Pathol; 2009 Jul; 218(3):399-408. PubMed ID: 19402129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
